Abstract: A display device includes a first electrode disposed on a substrate, a first insulating film disposed on the first electrode and having a first opening formed, a second insulating film disposed on the first insulating film and having a second opening, and a contact electrode electrically contacting at least a portion of the first electrode through the first opening and the second opening, wherein a side surface of the first insulating film defines the first opening, and the second insulating film overlaps the side surface of the first insulating film such that the contact electrode and the first insulating film are not in contact with each other.

Abstract: The present disclosure relates to a healable superplastic amorphous alloy, and specifically, to a healable superplastic amorphous alloy capable of exhibiting superplastic behavior and unique healable behavior by maximizing the complexity of the amorphous structure for an Icosahedral quenched-in nuclei quasi-crystal cluster to be formed in the amorphous matrix through the composition limitation and additive element control of Zr—Cu—Ni—Al alloy.

Abstract: A display device includes a substrate including an emission area and a non-emission area, alignment electrodes arranged to be spaced from each other in a first direction on the substrate and extending in a second direction crossing the first direction, and pixels arranged along the second direction. Pixels adjacent to each other in the second direction from among the pixels may be configured to emit light of different colors. Each of the pixels may include first light emitting elements on the alignment electrodes and arranged along the second direction, second light emitting elements on the alignment electrodes, spaced from the first light emitting elements in the first direction, and arranged along the second direction, a first pixel electrode electrically connected to a first driving power and first ends of the first light emitting elements, a second pixel electrode spaced from the first pixel electrode in the first direction.

Abstract: A display device may include pixels on a substrate. Each of the pixels may include: a first alignment electrode and a second alignment electrode located on the substrate and spaced from each other; a first insulating layer on the first alignment electrode and the second alignment electrode; a light emitting element located on the first insulating layer between the first and second alignment electrodes; a dummy pattern located between the first insulating layer and the light emitting element; a second insulating layer located on the light emitting element and exposing first and second ends of the light emitting element; a first electrode electrically connected to the first end of the light emitting element; and a second electrode spaced from the first electrode, and electrically connected to the second end of the light emitting element. The dummy pattern may include a same material as the second insulating layer.

Abstract: A display device includes: light emitting elements, each of the light emitting elements including a first end having a first polarity and a second end having a second polarity different from the first polarity; and a first type connection electrode contacting the first ends and/or the second ends of the light emitting elements, wherein a first type connection electrode includes: a middle portion extending in a first direction; a first electrode portion extending from the middle portion toward a first side in a second direction intersecting the first direction; a second electrode portion extending from the middle portion toward the first side in the second direction and spaced from the first electrode portion by a first width in the first direction; a third electrode portion extending from the middle portion toward a second side in the second direction; and a fourth electrode portion.

Abstract: The present invention relates to a drug delivery composition using crosslinked hyaluronic acid, a manufacturing method therefor, and a pharmaceutical composition comprising the drug delivery composition and a drug and having a desired release behavior.

Abstract: Provided is a positive active material for a lithium rechargeable battery that includes primary particles including a compound being capable of intercalating and deintercalating lithium, and secondary particles including the primary particles gathered with one another, wherein the secondary particles have a void core structure. A method of preparing the same and a lithium rechargeable battery including the same are also provided.